Study Index

NAD+ Study Index

NAD+ (nicotinamide adenine dinucleotide) is a dinucleotide coenzyme that serves as an electron carrier in cellular redox reactions and as a substrate for sirtuin deacylases (SIRT1 through SIRT7) and PARP enzymes involved in DNA strand break repair. Intracellular NAD+ levels decline substantially with age across multiple mammalian species, a decline that correlates with impaired sirtuin activity, reduced PARP-mediated DNA repair capacity, and mitochondrial dysfunction. Research supplementing NAD+ precursors including NMN and NR in animal models has demonstrated improvements in metabolic function, muscle health, and aging-related biomarkers, with the sirtuin and mitochondrial biogenesis pathways serving as the primary proposed effectors.

Studies Listed

6

Order NAD+ ($279)

Curated Study References

Click column headers to sort. PubMed links open in a new tab where available.

6 studies

Yoshino et al.

2021, Science

PMID ↗

NMN supplementation in postmenopausal prediabetic women improved skeletal muscle insulin signaling and gene expression compared to placebo, providing human clinical evidence for NAD+ precursor effects on metabolic function.

Rajman et al.

2018, Cell Metabolism

PMID ↗

Comprehensive review of in vivo evidence for NAD+ precursor supplementation across aging, metabolic disease, neurodegeneration, and DNA damage models, synthesizing the mechanistic basis for sirtuin and PARP activation as primary effectors.

Imai et al.

2013, Cell

PMID ↗

Review establishing the centrality of NAD+ decline to aging across species and documenting the sirtuin-mediated epigenetic, metabolic, and stress response consequences of reduced NAD+ availability in aging organisms.

Gomes et al.

2013, Cell

PMID ↗

NAD+ decline in aging mice disrupted nuclear-mitochondrial communication through HIF-1alpha pseudohypoxic signaling, causing a breakdown in mitochondrial homeostasis that was reversible by NMN supplementation, directly linking NAD+ to mitochondrial aging.

Yoshino et al.

2011, Cell Metabolism

PMID ↗

NMN supplementation in mouse models of diet-induced and age-induced metabolic disease restored NAD+ levels and reversed multiple metabolic dysfunction markers, providing a key preclinical study for NAD+ precursor supplementation research.

Guarente et al.

2000, Science

PMID ↗

Established that Sir2 (the yeast sirtuin) requires NAD+ as a substrate and links chromatin silencing to metabolic state through NAD+/NADH ratio sensing, providing the foundational mechanistic framework for NAD+ in aging and epigenetic research.

All citations are for informational research reference purposes. Always verify directly via PubMed for current status.

Research Questions

Common questions about NAD+ research context, mechanism, and procurement.

What is NAD+ and why does it decline with age?+
NAD+ is a dinucleotide coenzyme that serves as an electron carrier in cellular redox reactions and as a substrate for sirtuin and PARP enzymes. Intracellular NAD+ levels decline substantially with age across multiple mammalian species, a process linked to increased CD38 activity, reduced biosynthesis, and increased consumption by PARP enzymes responding to accumulated DNA damage.
What sirtuin research has been conducted linking NAD+ to aging?+
Guarente et al. (2000, Science) established that Sir2 (the yeast sirtuin homolog) requires NAD+ as a substrate and links chromatin silencing to metabolic state through NAD+/NADH ratio sensing. Imai et al. (2013, Cell) further reviewed the centrality of NAD+ decline to aging across species, documenting the metabolic, epigenetic, and stress response consequences of reduced NAD+ availability.
What mitochondrial research has been conducted on NAD+ supplementation?+
Gomes et al. (2013, Cell) documented that NAD+ decline in aging mice disrupted nuclear-mitochondrial communication through HIF-1alpha pseudohypoxic signaling, causing mitochondrial dysfunction that was reversible by NMN supplementation. This study established a direct mechanistic link between NAD+ availability and mitochondrial aging processes.
What human clinical research exists on NAD+ precursor supplementation?+
Yoshino et al. (2021, Science) documented that NMN supplementation in postmenopausal prediabetic women improved skeletal muscle insulin signaling and gene expression compared to placebo. This represents one of the more rigorous human data points for NAD+ precursor effects, though the broader literature remains primarily preclinical.

Related Compound Comparisons

Explore how NAD+ compares to other research compounds.

Source NAD+

NAD+ is available from Spartan Peptides at least 98% HPLC-verified purity. Domestic US supply with same-day dispatch before 2 PM. For in-vitro research use only.

Order NAD+ ($279)

For in-vitro research use only. Not intended for human consumption.